Jobs / United States / Astrazeneca Pharmaceuticals Lp

(Senior) Director, Clinical Pharmacology

Astrazeneca Pharmaceuticals Lp · 🇺🇸 2 Locations

Sponsorship verdict

Sponsorship possible

One solid signal, not two — worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
  • What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
  • Confirmed live todayWhen a source last listed this job as open.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.

Start free →

Or apply yourself on the official page →

Sponsor Radar — Astrazeneca Pharmaceuticals Lp

99 H-1B filings certified since Oct 2025

The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).

Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →

About the role

Summary Lead the clinical pharmacology (CP) group of ~10 members, including clinical pharmacologists, pharmacometricians and toxicologists, to support global and/or regional development projects, ensuring all deliverables are based on science with high quality and timeliness. Responsibilities • Provide CP expertise and guidance in clinical drug development programs of all therapeutic areas in study design (including dose rationales), data analyses to learn dose-exposure-response relationships and their variabilities, result interpretations and reporting • Supervise and work with pharmacometricians in conducting PK (and/or PD) analysis (e.g., to integrate all regional data and investigate ethnic differences) for regulatory submissions in China • Engage with management, regional and global (internal and external) stakeholders to drive CP strategies at project and portfolio levels • Establish best practices for CP processes activities (e.g., modeling and simulation) to seek efficiency. Implement and explore process and data analysis strategies including AI/ML for science/innovation and for productivity • Guide CP members in career development; coach and train junior members in applying quantitative methods and PK-PD knowledge to clinical projects Qualifications • Ph.D./PharmD/MD in relevant disciplines (CP, pharmacokinetics [PK], , toxicokinetics, pharmacometrics) or other equivalent degrees or knowledge/expertise • 8+ years of relevant clinical development experience in CP or Modeling & Simulation (M&S) roles • Adequate people management experience with proven track records as a coach/trainer • Excellent communication and negotiating skills with fluent in English (oral and written) • Decent scientific publication records Skills • In-depth understanding of CP, pharmacometrics, and their interfaces with (and good understanding of) DMPK, toxicology, biostatistics, clinical development, and regulatory science with quantitative, logical approach to drug development and common sensical business acumen. • Ability to translate complex quantitative analyses into clear, actionable insights for cross‑functional and senior stakeholders. • Strong scientific judgment, critical thinking, and decision‑making in ambiguous or data‑limited settings. • Experience of working in global, matrix organizations with high scientific and regulatory standards. Effective management of stakeholders Date Posted 29-9月-2026 Closing Date 30-12月-2026 AstraZeneca embraces diversity and equality of opportunity.  We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills.  We believe that the more inclusive we are, the better our work will be.  We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics.  We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.

View the official posting →

Source: Employer career site (Workday) First seen: 2026-10-01 Last confirmed: 2026-10-02 How our data works → Report this job

Similar opportunities